Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS

Research Site, Bunkyō City, Japan

Research Site, Hirakata-shi, Japan

Research Site, Iruma-Gun, Japan

Research Site, Kyoto, Japan

Research Site, Matsumoto-shi, Japan

Research Site, Miyazaki, Japan

Research Site, Nagoya, Japan

Research Site, Nara, Japan

Research Site, Nerima-ku, Japan

Research Site, Sapporo, Japan

Research Site, Shinjuku-ku, Japan

Research Site, Tsu, Japan